166 related articles for article (PubMed ID: 9728894)
1. Inhibition of chlorzoxazone metabolism, a clinical probe for CYP2E1, by a single ingestion of watercress.
Leclercq I; Desager JP; Horsmans Y
Clin Pharmacol Ther; 1998 Aug; 64(2):144-9. PubMed ID: 9728894
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of CYP2E1 by chlormethiazole as measured by chlorzoxazone pharmacokinetics in patients with alcoholism and in healthy volunteers.
Eap CB; Schnyder C; Besson J; Savary L; Buclin T
Clin Pharmacol Ther; 1998 Jul; 64(1):52-7. PubMed ID: 9695719
[TBL] [Abstract][Full Text] [Related]
3. A study on the pharmacokinetics of chlorzoxazone in healthy Thai volunteers.
Prompila N; Wittayalertpanya S; Komolmit P
J Med Assoc Thai; 2007 Jan; 90(1):160-6. PubMed ID: 17621748
[TBL] [Abstract][Full Text] [Related]
4. The effect of endotoxin administration on the pharmacokinetics of chlorzoxazone in humans.
Poloyac SM; Tosheva RT; Gardner BM; Shedlofsky SI; Blouin RA
Clin Pharmacol Ther; 1999 Dec; 66(6):554-62. PubMed ID: 10613610
[TBL] [Abstract][Full Text] [Related]
5. Impaired 6-hydroxychlorzoxazone elimination in patients with kidney disease: Implication for cytochrome P450 2E1 pharmacogenetic studies.
Nolin TD; Gastonguay MR; Bies RR; Matzke GR; Frye RF
Clin Pharmacol Ther; 2003 Dec; 74(6):555-68. PubMed ID: 14663458
[TBL] [Abstract][Full Text] [Related]
6. Modulation of CYP2E1 activity by isoniazid in rapid and slow N-acetylators.
O'Shea D; Kim RB; Wilkinson GR
Br J Clin Pharmacol; 1997 Jan; 43(1):99-103. PubMed ID: 9056059
[TBL] [Abstract][Full Text] [Related]
7. Urinary excretion of 6-hydroxychlorzoxazone as an index of CYP2E1 activity.
Dreisbach AW; Ferencz N; Hopkins NE; Fuentes MG; Rege AB; George WJ; Lertora JJ
Clin Pharmacol Ther; 1995 Nov; 58(5):498-505. PubMed ID: 7586943
[TBL] [Abstract][Full Text] [Related]
8. Effect of the acute-phase response on the pharmacokinetics of chlorzoxazone and cytochrome P-450 2E1 in vitro activity in rats.
Rockich K; Blouin R
Drug Metab Dispos; 1999 Sep; 27(9):1074-7. PubMed ID: 10460809
[TBL] [Abstract][Full Text] [Related]
9. Circadian rhythm of cytochrome P4502E1 and its effect on disposition kinetics of chlorzoxazone in rats.
Khemawoot P; Nishino K; Ishizaki J; Yokogawa K; Miyamoto K
Eur J Pharmacol; 2007 Nov; 574(1):71-6. PubMed ID: 17651723
[TBL] [Abstract][Full Text] [Related]
10. Effect of disulfiram-mediated CYP2E1 inhibition on the disposition of vesnarinone.
Frye RF; Tammara B; Cowart TD; Bramer SL
J Clin Pharmacol; 1999 Nov; 39(11):1177-83. PubMed ID: 10579149
[TBL] [Abstract][Full Text] [Related]
11. Chlormethiazole inhibition of cytochrome P450 2E1 as assessed by chlorzoxazone hydroxylation in humans.
Gebhardt AC; Lucas D; Ménez JF; Seitz HK
Hepatology; 1997 Oct; 26(4):957-61. PubMed ID: 9328319
[TBL] [Abstract][Full Text] [Related]
12. Effects of cigarette smoking and carbon monoxide on chlorzoxazone and caffeine metabolism.
Benowitz NL; Peng M; Jacob P
Clin Pharmacol Ther; 2003 Nov; 74(5):468-74. PubMed ID: 14586387
[TBL] [Abstract][Full Text] [Related]
13. Chlorzoxazone as a single sample probe of hepatic CYP2E1 activity in humans.
Bachmann K; Sarver JG
Pharmacology; 1996 Mar; 52(3):169-77. PubMed ID: 8849486
[TBL] [Abstract][Full Text] [Related]
14. Duration of cytochrome P-450 2E1 (CYP2E1) inhibition and estimation of functional CYP2E1 enzyme half-life after single-dose disulfiram administration in humans.
Emery MG; Jubert C; Thummel KE; Kharasch ED
J Pharmacol Exp Ther; 1999 Oct; 291(1):213-9. PubMed ID: 10490907
[TBL] [Abstract][Full Text] [Related]
15. The effect of isoniazid containing regimen on CYP2E1 during antituberculosis therapy.
Walubo A; Coetsee C; Arti D; Du Plessis JB
Res Commun Mol Pathol Pharmacol; 2005; 117-118():137-51. PubMed ID: 18426085
[TBL] [Abstract][Full Text] [Related]
16. Chlorzoxazone metabolism is increased in fasted Sprague-Dawley rats.
Wan J; Ernstgård L; Song BJ; Shoaf SE
J Pharm Pharmacol; 2006 Jan; 58(1):51-61. PubMed ID: 16393464
[TBL] [Abstract][Full Text] [Related]
17. Influence of diosmin pretreatment on the pharmacokinetics of chlorzoxazone in healthy male volunteers.
Rajnarayana K; Venkatesham A; Nagulu M; Srinivas M; Krishna DR
Drug Metabol Drug Interact; 2008; 23(3-4):311-21. PubMed ID: 19326774
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of intravenous chlorzoxazone in rats with dehydration and rehydration: effects of food intakes.
Kim YC; Kim YG; Kim EJ; Cho MK; Kim SG; Lee MG
Biopharm Drug Dispos; 2003 Mar; 24(2):53-61. PubMed ID: 12619050
[TBL] [Abstract][Full Text] [Related]
19. Effect of high-dose aspirin on CYP2E1 activity in healthy subjects measured using chlorzoxazone as a probe.
Park JY; Kim KA; Park PW; Ha JM
J Clin Pharmacol; 2006 Jan; 46(1):109-14. PubMed ID: 16397290
[TBL] [Abstract][Full Text] [Related]
20. Decrease of plasma and urinary oxidative metabolites of acetaminophen after consumption of watercress by human volunteers.
Chen L; Mohr SN; Yang CS
Clin Pharmacol Ther; 1996 Dec; 60(6):651-60. PubMed ID: 8988067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]